A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
Carolin Temps(Edinburgh Cancer Research), Asier Unciti‐Broceta(Edinburgh Cancer Research)
Cited by 52
Related Papers
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
|Nature Communications|2014|346
Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine
|Journal of Medicinal Chemistry|2014|200
Bioorthogonal Uncaging of Cytotoxic Paclitaxel through Pd Nanosheet–Hydrogel Frameworks
|Journal of Medicinal Chemistry|2020|53